Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene.

De novo activating mutations in the calcium-sensing receptor (CASR) gene are a common cause of sporadic isolated hypoparathyroidism. Here, we describe a family in which two affected siblings were found to be heterozygous for a novel F788L mutation in the fifth transmembrane domain encoded by exon 7 of the CASR. Both parents and the third sibling were clinically unaffected and genotypically normal by direct sequencing of their leukocyte exon 7 PCR amplicons. However, the mother was revealed to be a mosaic for the mutation by sequence analysis of multiple subclones as well as denaturing HPLC of the CASR exon 7 leukocyte PCR product. A functional analysis of the mutation was performed by transiently transfecting wild-type and mutant CASRs tagged with a c-Myc epitope in human embryonic kidney (HEK293) cells. The mutant CASR was expressed at a similar level as the wild type. The F788L mutant produced a significant shift to the left relative to the wild-type CASR in the MAPK response to increasing extracellular calcium concentrations. This is the first report of mosaicism for an activating CASR mutation and suggests that care should be exercised in counseling for risks of recurrence in a situation where a de novo mutation appears likely.

[1]  G. Hendy,et al.  CASRdb: calcium‐sensing receptor locus‐specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia , 2004, Human mutation.

[2]  Z. Pausova,et al.  Mapping of the calcium-sensing receptor gene (CASR) to human Chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat Chromosome 11 and mouse Chromosome 16 , 1995, Mammalian Genome.

[3]  A. Conigrave,et al.  Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  G. Hendy,et al.  Human Calcium-sensing Receptor Gene , 2002, The Journal of Biological Chemistry.

[5]  A. Lania,et al.  Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  E. Brown,et al.  Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. , 2002, The Journal of clinical endocrinology and metabolism.

[7]  E. Brown,et al.  Activating mutations of the calcium-sensing receptor: management of hypocalcemia. , 2001, The Journal of clinical endocrinology and metabolism.

[8]  G. Hendy,et al.  An acceptor splice site mutation in the calcium‐sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 2001, Human mutation.

[9]  J. Oldenburg,et al.  Somatic mosaicism in hemophilia A: a fairly common event. , 2001, American journal of human genetics.

[10]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[11]  J. Cheadle,et al.  Low level mosaicism detectable by DHPLC but not by direct sequencing , 2001, Human mutation.

[12]  E. Brown,et al.  Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. , 2001, American journal of physiology. Renal physiology.

[13]  E. Brown,et al.  Extracellular calcium sensing and extracellular calcium signaling. , 2001, Physiological reviews.

[14]  G. Hendy,et al.  Mutations of the calcium‐sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia , 2000, Human mutation.

[15]  S. Verhoef,et al.  High rate of mosaicism in tuberous sclerosis complex. , 1999, American journal of human genetics.

[16]  D. Kwiatkowski,et al.  Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. , 1999, The New England journal of medicine.

[17]  E. Brown,et al.  Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. , 1998, The Journal of clinical endocrinology and metabolism.

[18]  Joël Zlotogora,et al.  Germ line mosaicism , 1998, Human Genetics.

[19]  A. Green,et al.  Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. , 1997, Human molecular genetics.

[20]  M. Coulthard,et al.  A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. , 1996, The New England journal of medicine.

[21]  J. Baron,et al.  Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. , 1996, Human molecular genetics.

[22]  J. Naylor,et al.  Mendelian inheritance in man: A catalog of human genes and genetic disorders , 1996 .

[23]  V. McKusick Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders , 1997 .

[24]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[25]  J. Seidman,et al.  Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation , 1994, Nature Genetics.

[26]  J. Seidman,et al.  Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1993, Cell.

[27]  M. Hediger,et al.  Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.

[28]  P. Byers,et al.  Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). , 1990, American journal of human genetics.

[29]  V. McKusick Mendelian inheritance in man , 1971 .